Yayın:
Synthesis of hydroxyapatite crystals using carboxymethyl inulin for use as a delivery of ibuprofen

dc.contributor.authorOner, Mualla
dc.contributor.authorUysal, Umut
dc.contributor.institutionauthorÖNER, Mualla
dc.date.accessioned2026-06-27T13:20:31Z
dc.date.issued2013
dc.description.abstractIn the present study biodegradable, environmentally friendly polysaccharide-based polycarboxylate, carboxymethyl inulin (CMI), was used to produce hydroxyapatite (HAP) particles by wet chemical synthesis under controlled temperature, pH, and atmospheric conditions. The morphology and microstructure of the HAP nanoparticles were investigated by XRD, SEM, DTA-TGA and FTIR. CMI affects morphology, surface area, dimension and particle size distribution of the crystals. The reduction in size is greater in the direction of the c-axis. The increase in the polymer concentration to 7.5 g/L resulted in the mixture of nanoparticles with particle sizes of less than 100 nm. The SEM micrograph shows the formation of well-crystallized, agglomerated small particles of HAP. X-ray analysis has Shown that the resulting particles have high thermal stability. The obtained crystals were used to produce tablets by direct compression of HAP. The influence of sample's CMI concentration on drug release profiles was investigated by using ibuprofen (C13H18O2) as a model drug. The model was used to determine the effective diffusion coefficient of the drug from the tablets. A good agreement between experimental data and model predictions was obtained as calculated in the present work. The values of the diffusion coefficients range from 1.62 x 10(-7) to 4.72 x 10(-7) m(2) h(-1). (C) 2012 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipYTUAF [27-07-01-02]
dc.description.sponsorshipDPT [24-DPT-07-04-01, 25-DPT-07-04-01]
dc.description.urihttps://doi.org/10.1016/j.msec.2012.09.018
dc.identifier.doi10.1016/j.msec.2012.09.018
dc.identifier.endpage489
dc.identifier.issn0928-4931
dc.identifier.issue1
dc.identifier.pubmed25428099
dc.identifier.startpage482
dc.identifier.urihttps://hdl.handle.net/20.500.14981/51980
dc.identifier.volume33
dc.identifier.wos000313155500066
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofMATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
dc.subjectHydroxyapatite
dc.subjectNanomaterials
dc.subjectBiopolymers
dc.subjectDrug release
dc.subjectIbuprofen
dc.subjectTAILOR-MADE INHIBITORS
dc.subjectDRUG-RELEASE
dc.subjectIN-VITRO
dc.subjectOXALATE CRYSTALLIZATION
dc.subjectCALCIUM-OXALATE
dc.subjectGROWTH
dc.subjectPOLYELECTROLYTES
dc.subjectARCHITECTURE
dc.subjectMORPHOLOGY
dc.subjectACID
dc.subjectMaterials Science
dc.titleSynthesis of hydroxyapatite crystals using carboxymethyl inulin for use as a delivery of ibuprofen
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar